Literature DB >> 17113636

Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.

Suzan T M Nillesen1, Paul J Geutjes, Ronnie Wismans, Joost Schalkwijk, Willeke F Daamen, Toin H van Kuppevelt.   

Abstract

An important issue in tissue engineering is the vascularisation of the implanted construct, which often takes several weeks. In vivo, the growth factors VEGF and FGF2 show a combined effect on both angiogenesis and maturation of blood vessels. Therefore, we hypothesise that the addition of these growth factors to an acellular construct increases blood vessel formation and maturation. To systematically evaluate the contribution of each scaffold component with respect to tissue response and in particular to blood vessel formation, five porous scaffolds were prepared and characterised, viz.: collagen, collagen with heparin, and collagen with heparin plus one or two growth factors (rrFGF2 and rrVEGF). Scaffolds were subcutaneously implanted in 3 months old Wistar rats. Of all scaffolds tested, the one with a combination of growth factors displayed the highest density of blood vessels (type IV collagen) and most mature blood vessels (smooth muscle actin). In addition, no hypoxic cells were found in this scaffold at day 7 and 21 (hypoxia inducible factor 1-alpha). These results indicate that the addition of both FGF2 and VEGF to an acellular construct enhances an early mature vasculature. This opens prospects for (acellular) tissue-engineered constructs in conditions as ischaemic heart disease or diabetic ulcers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113636     DOI: 10.1016/j.biomaterials.2006.10.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  78 in total

Review 1.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

2.  The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration.

Authors:  Jongman Lee; James J Yoo; Anthony Atala; Sang Jin Lee
Journal:  Biomaterials       Date:  2012-07-06       Impact factor: 12.479

3.  Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing.

Authors:  Caitlin G Decker; Yu Wang; Samantha J Paluck; Lu Shen; Joseph A Loo; Alex J Levine; Lloyd S Miller; Heather D Maynard
Journal:  Biomaterials       Date:  2015-12-15       Impact factor: 12.479

4.  Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.

Authors:  Ying Wang; Xiao-Cheng Liu; Jian Zhao; Xiang-Rong Kong; Rong-Fang Shi; Xiao-Bin Zhao; Cun-Xian Song; Tian-Jun Liu; Feng Lu
Journal:  Tex Heart Inst J       Date:  2009

Review 5.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 6.  Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials.

Authors:  James J Moon; Jennifer L West
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

7.  Engineering a vascularized collagen-β-tricalcium phosphate graft using an electrochemical approach.

Authors:  Yunqing Kang; Naoto Mochizuki; Ali Khademhosseini; Junji Fukuda; Yunzhi Yang
Journal:  Acta Biomater       Date:  2014-09-28       Impact factor: 8.947

8.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 9.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

10.  Bioerodible system for sequential release of multiple drugs.

Authors:  Sharath C Sundararaj; Mark V Thomas; Thomas D Dziubla; David A Puleo
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.